Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label single-dose mass balance and absolute bioavailability study of oral ONO-5788 in healthy adult men
NL-OMON48245Active, not recruiting
- Sponsor
- Ono Pharmaceutical
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ONO-5788 in acromegaly (2 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Absolute bioavailability of ONO-5788 in plasma and Total recovery of radioactivity in urine and feces. Started Jan 2019; status: active, not recruiting.
02
Drugs
ONO-5788
03
Conditions
acromegaly
Beyond the preview
Go deeper on NL-OMON48245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48245.